Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,957
Views
13
CrossRef citations to date
0
Altmetric
Back Matter

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

Wouter W. van Willigena Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands;b Department of Medical Oncology, Radboudumc, Nijmegen, The NetherlandsView further author information
,
Martine Bloemendala Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands;b Department of Medical Oncology, Radboudumc, Nijmegen, The NetherlandsView further author information
,
Marye J. Boers-Sonderenb Department of Medical Oncology, Radboudumc, Nijmegen, The NetherlandsView further author information
,
Jan Willem B. de Grootc Department of Medical Oncology, Isala Oncology Center, Zwolle, The NetherlandsView further author information
,
Rutger H.T. Koornstrab Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands;d Department of Internal Medicine, Hospital Rijnstate, Arnhem, The NetherlandsView further author information
,
Astrid A.M. van der Veldte Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands;f Department of Radiology & Nuclear Medicine, Erasmus Medical Center Cancer Institute, Rotterdam, The NetherlandsView further author information
,
John B. A. G. Haaneng Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsView further author information
,
Steve Boudewijnsh Department of Medical Oncology, Bravis Hospital, Roosendaal, The NetherlandsView further author information
,
Gerty Schreibelta Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The NetherlandsView further author information
,
Winald R. Gerritsenb Department of Medical Oncology, Radboudumc, Nijmegen, The NetherlandsView further author information
,
I. Jolanda M. de Vriesa Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands;b Department of Medical Oncology, Radboudumc, Nijmegen, The NetherlandsCorrespondence[email protected]
View further author information
&
Kalijn F. Bola Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands;b Department of Medical Oncology, Radboudumc, Nijmegen, The NetherlandsView further author information
 show all
Article: 1738814 | Received 24 Dec 2019, Accepted 25 Jan 2020, Published online: 22 Mar 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now

Articles from other publishers (12)

Laura Hato, Angel Vizcay, Iñaki Eguren, José L. Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio & Marta Santisteban. (2024) Dendritic Cells in Cancer Immunology and Immunotherapy. Cancers 16:5, pages 981.
Crossref
Ignacio Heras-Murillo, Irene Adán-Barrientos, Miguel Galán, Stefanie K. Wculek & David Sancho. (2024) Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nature Reviews Clinical Oncology.
Crossref
Paolo Zuccolini, Raffaella Barbieri, Francesca Sbrana, Cristiana Picco, Paola Gavazzo & Michael Pusch. (2023) IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration. International Journal of Molecular Sciences 24:22, pages 16285.
Crossref
Robert C. Subtirelu, Eric M. Teichner, Arjun Ashok, Chitra Parikh, Sahithi Talasila, Irina-Mihaela Matache, Ahab G. Alnemri, Victoria Anderson, Osmaan Shahid, Sricharvi Mannam, Andrew Lee, Thomas Werner, Mona-Elisabeth Revheim & Abass Alavi. (2023) Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma. Frontiers in Neurology 14.
Crossref
Chiara Ursino, Cécile Mouric, Laurent Gros, Nathalie Bonnefoy & Julien Faget. (2023) Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness. Frontiers in Immunology 14.
Crossref
Jifeng Yu, Hao Sun, Weijie Cao, Yongping Song & Zhongxing Jiang. (2022) Research progress on dendritic cell vaccines in cancer immunotherapy. Experimental Hematology & Oncology 11:1.
Crossref
Payal Aggarwal, Wen Luo, Katherine C. Pehlivan, Hai Hoang, Prajwal Rajappa, Timothy P. Cripe, Kevin A. Cassady, Dean A. Lee & Mitchell S. Cairo. (2022) Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations. Frontiers in Immunology 13.
Crossref
Paolo Zuccolini, Loretta Ferrera, Alessia Remigante, Cristiana Picco, Raffaella Barbieri, Sara Bertelli, Oscar Moran, Paola Gavazzo & Michael Pusch. (2022) The VRAC blocker DCPIB directly gates the BK channels and increases intracellular Ca 2+ in melanoma and pancreatic duct adenocarcinoma cell lines . British Journal of Pharmacology 179:13, pages 3452-3469.
Crossref
Ivan Y. Filin, Kristina V. Kitaeva, Catrin S. Rutland, Albert A. Rizvanov & Valeriya V. Solovyeva. (2021) Recent Advances in Experimental Dendritic Cell Vaccines for Cancer. Frontiers in Oncology 11.
Crossref
Alexander Batista-Duharte, Alejandra Pera, Salvador F. Aliño & Rafael Solana. (2021) Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects. International Immunopharmacology 96, pages 107761.
Crossref
Iris A. E. van der Hoorn, Georgina Flórez-Grau, Michel M. van den Heuvel, I. Jolanda M. de Vries & Berber Piet. (2021) Recent Advances and Future Perspective of DC-Based Therapy in NSCLC. Frontiers in Immunology 12.
Crossref
Henner Stege, Maximilian Haist, Michael Schultheis, Maria Isabel Fleischer, Peter Mohr, Friedegund Meier, Dirk Schadendorf, Selma Ugurel, Elisabeth Livingstone, Lisa Zimmer, Rudolf Herbst, Claudia Pföhler, Katharina Kähler, Michael Weichenthal, Patrick Terheyden, Dorothée Nashan, Dirk Debus, Martin Kaatz, Fabian Ziller, Sebastian Haferkamp, Andrea Forschner, Ulrike Leiter, Alexander Kreuter, Jens Ulrich, Johannes Kleemann, Fabienne Bradfisch, Stephan Grabbe & Carmen Loquai. (2021) Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study. Cancers 13:10, pages 2312.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.